BSE filing, NSE: AAREYDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarey Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹110.84
- Market cap
- ₹314.3 Cr
- Revenue (annual)
- ₹472.3 Cr
- Net profit (annual)
- ₹3.97 Cr
- P/E (TTM)
- 75.3×Sector 48.7×
- Promoter holding
- 41.45%+3.74% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarey Drugs & Pharmaceuticals Ltd
All →Aarey Drugs & Pharmaceuticals Other Announcement
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulations.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs approved allotment of 1,150,000 equity shares from warrant conversion at ₹47.85 each, receiving ₹5.50 Crore. Issued capital rises to 31,874,303 shares.
- Value
- ₹5.50 Cr
Aarey Drugs & Pharmaceuticals Capital Structure Change
Promoter and promoter group of Aarey Drugs & Pharmaceuticals Ltd acquired 23.70 lakh shares following the conversion of warrants. The acquisition increased their stake by 4.81%.
- Promoter stake change
- +4.81%
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs allotted equity shares to promoters following the conversion of 23,40,000 warrants. This capital structure change increases the promoters' equity stake in the company.
- Value
- ₹11.20 Cr
Aarey Drugs & Pharmaceuticals Annual General Meeting
Aarey Drugs & Pharmaceuticals Ltd. held its 36th Annual General Meeting on September 30, 2026, to conduct business including financial statement adoption and director re-appointment.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs & Pharmaceuticals Ltd approved the allotment of 11,50,000 equity shares following the conversion of warrants. The allotment aggregate value is Rs. 7.34 Crore.
- Value
- ₹7.34 Cr
Other other announcement announcements
All →Vardhman Special Steels Other Announcement
Vardhman Special Steels filed the Crisil Monitoring Agency Report for the quarter ended 30 September 2026. It reports no deviation from the preferential issue's use of proceeds.
Three M Paper Boards Other Announcement
Three M Paper Boards filed its Reg 13(3) investor grievance report. All complaint categories for the quarter show NIL figures.
Manika Plastech Other Announcement
Manika Plastech intimated a change in its CIN from U- to L-prefixed code following its September 2026 listing. This is a routine MCA registry update with no transactional or business substance.
Symphony Other Announcement
Symphony Limited informed exchanges that management will appear on CNBC Bajar Gujarati on October 30, 2026, to discuss Q2 financial results and business outlook. No new business information is disclosed in this scheduling notice.
Decorous Investment & Trading Co Other Announcement
Decorous Investment submitted quarterly compliance certificates for the quarter ended 30.09.2026. The filing holds only routine SEBI LODR disclosures with no transactional or financial substance.
STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.